Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Filings indexed 1,205 across all filing types
Latest filing 2022-10-11 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
I, Kunal N Gandhi S/o Late Shri. Narendra I Gandhi, Promoter/Promoter Group of Lyka Labs Limited; file herewith Form C for Disclosure under Regulation 7 (2) read with Regulation 6 (2) ....
Regulatory Filings
2022-10-11 English
Insider Trading - Others
Regulatory Filings Classification · 95% confidence The document text is very short (1528 characters) and consists solely of multiple digital signature blocks by the same individual, Kunal Narendra Gandhi, with no substantive content such as financial data, report titles, or announcements. There is no indication of any report, meeting, or financial disclosure. The content is primarily certification or attestation in nature, which aligns with officer certification or confirmation letters. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2022-10-11 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Company has received an intimation from M/s Link ....
Regulatory Filings
2022-10-11 English
Loss of share certificate
Regulatory Filings
2022-10-11 English
Postal Ballot
Regulatory Filings
2022-10-10 English
With reference to e-postal ballot process undertaken by Lyka Labs Limited for seeking approval of the Members for - 1. Sale of land at Dharampur, Valsad and premises situated at Shivshakti ....
Regulatory Filings
2022-10-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.